|
|
Tenet Healthcare Corp (THC) |
|
Price: $74.5700
$2.02 
2.784%
|
| Day's High:
| $74.13
| Week Perf:
| 6.09 %
|
| Day's Low: |
$ 73.41 |
30 Day Perf: |
8.54 % |
| Volume (M): |
29 |
52 Wk High: |
$ 74.13 |
| Volume (M$): |
$ 2,160 |
52 Wk Avg: |
$56.60 |
| Open: |
$71.00 |
52 Wk Low: |
$36.69 |
|
|
| Market Capitalization (Millions $) |
7,905 |
| Shares
Outstanding (Millions) |
106 |
| Employees |
108,000 |
| Revenues (TTM) (Millions $) |
19,450 |
| Net Income (TTM) (Millions $) |
1,017 |
| Cash Flow (TTM) (Millions $) |
-639 |
| Capital Exp. (TTM) (Millions $) |
842 |
Tenet Healthcare Corp
Tenet Healthcare Corporation operates in one line of business'the provision of
health care, primarily through the operation of general acute care hospitals.
All of Tenets operations are conducted through its subsidiaries.'Tenet is the
second largest investor-owned health care services company in the United States.
Company Address: 14201 Dallas Parkway Dallas 75254 TX
Company Phone Number: 893-2200 Stock Exchange / Ticker: NYSE THC
| THC is expected to report next financial results on July 28, 2023. |
|
|
|
|
Customers Net Income grew by |
THC's Customers Net Profit Margin grew to |
10.94 % |
5.05 %
|
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
|
Ethema Health Corporation
The first quarter of 2023 financial report for Ethema Health Corporation may have reached break-even at $0.00 per share, but the company's surge in revenue is a good sign of things to come. Despite the fact that revenues jumped by an impressive 27.043% to $1.30 million from the same financial reporting period a year before, the net deficit was higher than the previous year at $-0.182 million.
While it is concerning to see an increase in net deficit, it is important to note that operating earnings improved by 0.11% to $0.075026 million. This shows that the company is on the right track and is taking steps towards profitability in the future.
|
|
Jrsis Health Care Corp
Jrsis Health Care Corp, a leading healthcare provider, recently released its financial results for the fiscal first quarter of 2023. The company reported a net deficit of $-0.119 million, a significant drop from the net income of $2.639 million recorded in the same reporting period the year before.
The company's earnings per share also dropped to $0.00, compared to $0.10 a year before and -$0.03 from the preceding reporting period. Meanwhile, the revenue remained unchanged at $0.00 million from $15.62 million in the same reporting period a year before and sequentially from $-15,530.25 million.
The company's net deficit is mainly attributed to its $0.00 million impairment of assets, which significantly impacted its financial standing. Without this impairment of assets, the company would still find it challenging to break even.
|
|
Imac Holdings Inc
Imac Holdings Inc Releases Q1 2023 Financial Results: Revenue Tumbled and Net Losses Rose Compared to Last Year
Imac Holdings Inc, a leading provider of healthcare services, recently announced its financial results for the first quarter ended March 31, 2023. Despite some positive developments, the company faced challenges in this reporting season, with a drop in revenue and an increase in net losses. Here are the key details of Imac Holdings' Q1 2023 financial performance:
Revenue: Imac Holdings' revenue for the first quarter of 2023 was $2.09 million, reflecting a decline of 46.255% from the same reporting period a year earlier, when it generated revenue of $3.89 million. Sequentially, the revenue declined by 39.697% compared to the last reporting season, which reported revenue of $3.47 million. The significant drop in revenue can be attributed to various factors, such as the economic slowdown, reduced patient volume, and lower reimbursement rates.
Net Losses: In the first quarter of 2023, Imac Holdings reported a net shortfall of $-3.699 million, which was higher than $-3.162 million a year earlier. This showed that the company's net losses surged compared to last year's reporting season. The increased net losses could be due to higher operating and administrative expenses, lower revenues, and slower reimbursements.
|
|
Pacific Health Care Organization Inc
As a journalist and financial analyst, I have been closely following the latest financial results of Pacific Health Care Organization Inc. for the first quarter of 2023. Upon analyzing the company's latest earnings report, there are some notable highlights and areas of concern that need to be discussed.
Firstly, let's take a closer look at Pacific Health Care Organization Inc.'s earnings per share (EPS) for the first quarter of 2023. The good news is that EPS remained unscathed at $0.01 per share, compared to the same period last year. However, it's important to note that EPS was $0.00 in the preceding reporting period. This indicates that there has been some progress but a lot more needs to be done to ensure consistent positive results.
|
|
Emmaus Life Sciences Inc
Emmaus Life Sciences Inc. has recently announced excellent financial results with a staggering year-on-year revenue growth of 108.813% amounting to $6.75 million in the first quarter of 2023. However, it is worth noting that Emmaus recorded an increased shortfall per share of $-0.07, a significant jump from $0.00 per share reported in the prior period. Despite this, the company's revenue has surged upwards by 13.879% compared to the previous year's $5.93 million.
The fiscal time-frame ending March 31, 2023, saw Emmaus Life Sciences Inc. record a net shortfall of $-3.527 million, which is considerably higher than the $-1.542 million realized in the previous year.
|
| Per Share |
Current |
| Earnings (TTM) |
3.74 $ |
| Revenues (TTM) |
183.48 $
|
| Cash Flow (TTM) |
- |
| Cash |
7.23 $
|
| Book Value |
24.34 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
3.74 $
|
| Revenues (TTM) |
183.48 $ |
| Cash Flow (TTM) |
- |
| Cash |
7.23 $
|
| Book Value |
24.34 $ |
| Dividend (TTM) |
0 $ |
|
|
| Tenet Healthcare's Operating Statistics
|
Decrease / Increase
|
| |
|
|
|
| Hospital Occupancy % |
|
 |
|
| Patient days |
|
|
 |
| Admissions |
|
|
|
| Adjusted admissions |
|
|
|
| Total surgeries |
|
|
|
| Outpatient revenue in millions $ |
|
|
|
| Inpatient revenue in millions $ |
|
|
|
| Net inpatient revenue per admission $ |
|
|
|
| Net inpatient revenue per patient day $ |
|
|
|
| Net outpatient revenue per visit $ |
|
|
|
|
|
3.83%